profit from every DKK 100 of sales.
DKK 0DKK 100
Ambu
DKK 86.40-0.58% today
+0.9% in 1 year
1-year low DKK 58.901-year high DKK 91.25
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
0%20% a year
You pay DKK 95.83 for every DKK 1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Ambu sold, what it kept, and what it did with the cash.
Sales went from DKK 4.01 billion in 2021 to DKK 5.39 billion in 2024, with DKK 235 million of profit last year.
SalesProfit
Ambu vs. similar companies
Ambu grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from DKK 100 of sales | Sales growth a year | Price per DKK 1 of profit |
|---|---|---|---|
| Ambu | 95.8× · Very expensive | ||
 Abbott Laboratories | 29.3× · Fair price | ||
 Medtronic | 27.1× · Fair price | ||
 Stryker | 38.0× · Expensive | ||
 Edwards Lifesciences | 55.7× · Expensive |
AI analysis
An AI analyst reads Ambu's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of DKK | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 4,013 | 4,444 | 4,775 | 5,391 | |
| 2,503 | 2,554 | 2,713 | 3,201 | |
| 340 | 122 | 302 | 645 | |
| 550 | 492 | 619 | 1,023 | |
| 247 | 93 | 168 | 235 | |
| 0.98 | 0.37 | 0.64 | 0.88 | |
| 62.4% | 57.5% | 56.8% | 59.4% | |
| 8.5% | 2.7% | 6.3% | 12.0% | |
| 6.2% | 2.1% | 3.5% | 4.4% |
Balance sheet
| In millions of DKK | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 5,740 | 7,215 | 6,859 | 7,154 |
| Cash | 64 | 187 | 157 | 615 |
| Total debt | 823 | 1,845 | 584 | 558 |
| Total liabilities | 1,788 | 2,954 | 1,466 | 1,560 |
| 3,952 | 4,261 | 5,393 | 5,594 | |
| 253 | 254 | 261 | 267 | |
| 5.5% | 1.8% | 3.6% | 4.2% | |
| 6.3% | 2.2% | 3.1% | 4.2% |
Cash flow
| In millions of DKK | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 328 | 95 | 518 | 813 | |
| 584 | 553 | 326 | 289 | |
| -256 | -458 | 192 | 524 | |
| Dividends paid | 73 | 75 | – | – |
| – | – | – | – | |
| 11 | 12 | 17 | 26 |
Valuation
- 95.8×
- –
- –
- 3.0×
- 4.2×
- 43.0×
- 22.0×
- 2.3%
- 1.0%
- –
Profitability
- 59.4%
- 12.0%
- 4.4%
- –
- 4.1%
- 3.7%
- –
- –
- –
- –
Growth
- +10.3%
- −3.5%
- –
- –
- +1.7%
Financial health
- -0.1×
- 0.10
- –
- 12.1×
- 2.49
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 46%of 953
Top 43%of 877
Bottom 9%of 564
Bottom 47%of 871
Top 39%of 988
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
49No pass
Benjamin Graham
42No pass
Philip Fisher
35No pass
Peter Lynch
30No pass
Joel Greenblatt
1No pass
Charlie Munger
38No pass
Terry Smith
41No pass
Questions about Ambu
Is Ambu a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Ambu AI analysis
What does Ambu do?
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. It is in Medical Devices, based in Ballerup, Denmark, with 5,200 employees.
Is Ambu stock halal?
Yes. Ambu passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
How has Ambu stock done over the past year?
Up 0.9% over the past twelve months, to DKK 86.40. It traded between DKK 58.90 and DKK 91.25 and is 5.3% below its high.
Who are Ambu's competitors?
The largest listed companies in the same industry are Abbott Laboratories, Medtronic, Stryker and Edwards Lifesciences. The peers table on this page compares their profit, growth and price with Ambu's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.